Both genetic depletion and pharmacological inhibition of ALDH1B1 significantly reduced metastatic burden and extended median survival in nude mouse models, highlighting its potential to suppress metastatic recurrence in post-operative cancer patients. The gene discussed is ALDH1B1; the disease is cancer.